The best AI for answering clinical questions with citations in 2026

OpenEvidence is the tool most US physicians reach for first — the company reports use by more than 40% of US physicians and raised at a $12 billion valuation in January 2026 ^[12] — and for a single, well-formed question it returns a cited synthesis faster than anything else here, with tiered models for a quick answer or a deeper survey ^[3]. It ranks second, not first, for four reasons the marketing does not lead with. It is gated to a US National Provider Identifier, which excludes most of the world's clinicians and nearly all students ^[3]. It withdrew from the EU and the UK on 28 April 2026, citing regulatory uncertainty including the EU AI Act, and existing accounts were blocked too ^[11]. It is funded by pharmaceutical advertising adjacent to the clinical answer ^[3]. And it shows no reasoning: you get a cited conclusion with no way to see what was weighed. In the June 2026 Nature Medicine evaluation — 500 MedQA items, 500 HealthBench items and 100 real clinician queries reviewed blind by 12 US clinicians — it was outperformed on all three by GPT-5.2, Gemini 3.1 Pro and Claude Opus 4.6, and clinicians preferred the general models' answers ^[9]. Excellent lookup; not the whole job.

UpToDate Expert AI answers a clinical question from the corpus most hospitals already trust — more than 7,600 clinician authors, editorially reviewed — and returns the answer with inline links to the underlying topics, surfaced assumptions and a step-by-step rationale ^[4]. For a settled, well-covered topic it is the safest answer on this page, because the source is a physician-written review rather than a synthesis of primary papers. Three things keep it third. The AI layer is sold on the $699-a-year Pro Plus tier for individual subscribers in the US and Canada, so a clinician elsewhere may hold UpToDate through an institution without the Expert AI layer ^[4]. It answers in English. And Wolters Kluwer publishes no clinical accuracy figure for Expert AI, while the one independent test that exists — Nature Medicine, June 2026 — found it outperformed by general frontier models on knowledge, HealthBench and real clinician questions ^[9]. Keep it; pair it with a tool that reasons in the open.

OpenAI launched ChatGPT for Clinicians on 22 April 2026 as a free tier for NPI-verified US physicians, nurse practitioners, physician assistants and pharmacists, running on GPT-5.4, which scored 59.0 on OpenAI's HealthBench Professional — above other frontier models and above physicians given unlimited time and web access ^[5][6]. It includes a clinical search that returns answers with citations, and a Business Associate Agreement that is optional and must be executed by the clinician before any patient data is entered; until then it is standard ChatGPT with respect to PHI ^[6]. It is the strongest general reasoner on this page and the Nature Medicine result — general frontier models beating the retrieval-only clinical tools — is the reason it ranks above the incumbents it used to trail ^[9]. It sits fourth because it is a general model with a clinician interface: not fine-tuned on clinical reasoning, its reasoning shown as a summary rather than a full chain, no country tailoring, and unavailable in the UK and EEA ^[5]. Superb for the work around the decision; use something above it when the citation has to be the source.

Doximity Ask — formerly DoxGPT — answers clinical questions with inline citations from a physician-curated evidence library and full-text access to more than 2,000 journals, runs a PeerCheck programme in which more than 12,000 physicians review AI answers, and offers a slower Thinking mode that shows its working ^[7]. In the independent NOHARM clinical-safety study led by Stanford and Harvard physician researchers (July 2026, 1,100 scenarios across 10 specialties) it outranked OpenEvidence and several frontier models on avoiding harmful recommendations ^[13]. For a US clinician who already has Doximity open for the dialer, CME or messaging, it is the answer with no new login. It ranks fifth because it is built on US clinician verification and a US network — not a realistic option elsewhere — and because the reasoning is a summary in one mode rather than a full auditable chain.

ClinicalKey AI answers from more than 1,000 full-text medical journals updated every 24 hours plus clinical overviews and guidelines, and lets you trace the evidence behind an answer to the paragraph it was cited from — the finest provenance in this comparison, finer than EvidenceMD's document-level citation ^[8]. It integrates with Epic through Connection Hub, which puts the cited answer on the same screen as the chart. It ranks sixth because it is an institutional licence only — no individual clinician can buy it — and because Elsevier publishes no accuracy figure for the generative layer and exposes no reasoning chain. If your hospital has it, it is the reference of record for the sentence you will cite; the reasoning still happens elsewhere.

DynaMedex pairs DynaMed's explicitly graded evidence summaries with Micromedex drug content, and Dyna AI — commercially launched in July 2024 — answers questions conversationally over that corpus with citations ^[14]. Its distinctive value for a clinical question is the grade: you see how strong the evidence behind a recommendation is, which no other tool here states as plainly, and the drug data sits in the same product. It ranks last for the same structural reasons as its neighbour: no inspectable reasoning, no published accuracy for the generative layer, and an institutional or library licence rather than an individual product. Worth checking whether your hospital, university or public library already provides it before paying for anything else.